| Bioactivity | Metallo-β-lactamase-IN-9 (Compound 23) is a pan metallo-beta-lactamase (MBL) inhibitor with IC50s of 35, 269 and 369 nM against NDM-1, VIM-1 and IMP-1, respectively[1]. |
| Target | IC50: 35 nM (NDM-1), 269 nM (VIM-1), 369 nM (IMP-1) |
| In Vivo | Metallo-β-lactamase-IN-9 (Compound 23) (10 and 50 mg/kg; s.c.; three times a day for 1 day) 在小鼠 Klebsiella pneumoniae MB9249 感染模型中与 Imipenem (HY-B1369A) 联用减少脾脏和肾脏的细菌负担[1]。Mouse Pharmacokinetic Properties of Metallo-β-lactamase-IN-9 (Compound 23)d[1] dosea(iv, mpk) |
| Name | Metallo-β-lactamase-IN-9 |
| Formula | C13H12N6O3S |
| Molar Mass | 332.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mandal M, et al. Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates. J Med Chem. 2022 Dec 22;65(24):16234-16251. |